Tip for Patients: Let your doctor know if you notice unusual changes in your blood pressure or heart rate while on semaglutide
The half-life of semaglutide is approximately seven days, or about 168 hours
Recently, it has been popularly labeled "natures Ozempic," referencing its claimed similarities to the pharmaceutical agent Ozempic (semaglutide), a glucagon-like peptide-1 (GLP-1) receptor agonist approved for managing type 2 diabetes mellitus and facilitating weight loss
The presence or absence of nausea, vomiting, or diarrhea does not determine weight loss success, and the medication remains highly effective even in users who experience minimal to no gastrointestinal symptoms
Because semaglutide targets receptors at the interface between the gut and the brain, gastrointestinal symptoms are part of its mechanism, not merely side effects